v3.25.2
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY (UNAUDITED) - USD ($)
Total
Common Class B
Common Stock
Common Class B
Additional Paid-in Capital
Accumulated Deficit
Share outstanding, beginning balance (in shares) at Dec. 31, 2022 [1]     12,500,000    
Shareholder's equity, beginning balance at Dec. 31, 2022 [1] $ 8,961   $ 1,250 $ 23,750 $ (16,039)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Sale of private placement warrants 14,300,000     14,300,000  
Fair value of public warrants at issuance 2,625,000     2,625,000  
Accretion of Class A ordinary shares to redemption amount (54,113,481)     (16,948,750) (37,164,731)
Net income 16,915,460       16,915,460
Share outstanding, ending balance (in shares) at Dec. 31, 2023   12,500,000 12,500,000 [1]    
Shareholder's equity, ending balance at Dec. 31, 2023 (20,264,060) [1]   $ 1,250 [1] 0 (20,265,310) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accretion of Class A ordinary shares to redemption amount (6,848,901)       (6,848,901)
Net income 6,393,390       6,393,390
Share outstanding, ending balance (in shares) at Mar. 31, 2024     12,500,000    
Shareholder's equity, ending balance at Mar. 31, 2024 (20,719,571)   $ 1,250 0 (20,720,821)
Share outstanding, beginning balance (in shares) at Dec. 31, 2023   12,500,000 12,500,000 [1]    
Shareholder's equity, beginning balance at Dec. 31, 2023 (20,264,060) [1]   $ 1,250 [1] 0 (20,265,310) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accretion of Class A ordinary shares to redemption amount (27,761,686)       (27,761,686)
Net income 25,986,159       25,986,159
Share outstanding, ending balance (in shares) at Dec. 31, 2024   12,500,000 12,500,000    
Shareholder's equity, ending balance at Dec. 31, 2024 (22,039,587)   $ 1,250 0 (22,040,837)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accretion of Class A ordinary shares to redemption amount (5,698,441)       (5,698,441)
Net income 2,992,795       2,992,795
Share outstanding, ending balance (in shares) at Mar. 31, 2025   12,500,000 12,500,000    
Shareholder's equity, ending balance at Mar. 31, 2025 $ (24,745,233)   $ 1,250 $ 0 $ (24,746,483)
[1] On April 25, 2023, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. All share amounts have been retroactively restated to reflect the share surrender and share recapitalization events and the share forfeitures (see Note 4).